MNMD Latest Headlines

Wall Street Analysts Are Bullish on Top Healthcare Picks

at www.tipranks.com (Mon, 12-Jan 10:50 PM)

Definium Therapeutics: De-Risked Late-Stage Neuropsychiatric Pipeline Positions 2026 as Catalyst-Rich Year Supporting Buy Rating and $32 Target

at www.tipranks.com (Mon, 12-Jan 9:51 PM)

Definium Therapeutics Rebrands and Highlights 2026 Pipeline

at www.tipranks.com (Mon, 12-Jan 8:56 AM)

MindMed Awards New Inducement Grant: What This Signals About Its Growth Ambitions

Market Chameleon (Tue, 4-Nov 8:51 AM)

MindMed Schedules Q3 2025 Earnings Release—Investor Focus Shifts to Late-Stage Pipeline

Market Chameleon (Fri, 31-Oct 11:24 AM)

MindMed Launches $225 Million Public Offering to Accelerate Brain Health Innovations

Market Chameleon (Thu, 30-Oct 8:13 AM)